GlassScriptPhysician profile
Laith Alzweri
NPI 1285173690
$10,121.65
in general payments reported to CMS, 2019-2025
10 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $1,096 · 2021: $645 · 2022: $1,272 · 2023: $4,897 · 2024: $760 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,822 · Food and Beverage: $3,064 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,821.59 |
| Food and Beverage | $3,063.86 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,603.43 | 2020-2025 | Titan, Porges Coloplast, Altis |
| Boston Scientific Corporation | $3,389.26 | 2020-2025 | Moses 550 D\F\L, Moses, Moses 550 Dfl |
| Endo Pharmaceuticals INC. | $404.96 | 2020-2023 | Aveed, Xiaflex |
| Endo USA, INC. | $146.19 | 2025 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $124.14 | 2024 | Prolaris |
| Antares Pharma, INC. | $100.00 | 2022 | |
| Healthtronics Stone Solutions, LLC | $56.59 | 2020 | |
| Medtronic, INC. | $47.06 | 2023 | Interstim |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Abc Home Medical Supply, INC. | $27.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laith Alzweri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.